Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

University Hospital, Linkoeping · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
adverse-eventpulmonarytuberculosis
tuberculosis, pulmonary, drug-susceptible pulmonary tuberculosis, rifampicin, pyrazinamide, shorter tuberculosis treatment, pharmacokinetics/pharmacodynamics, pk/pd, tb, adverse event, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834478
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.